Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start

The Alzheimer's drug Leqembi from Biogen and Eisai is seeing a slow launch, but demand is rising. Meanwhile, headsets are making some users nauseous.